Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Monk

Showing results (51-60 of 738) with videos related to

Pageof 74
Sort By:
Current Oncology Reports|June 8, 2001
Prevention of cervical cancer with vaccinesS S Im, B J Monk, L P Villarreal
American Journal of Obstetrics and Gynecology|May 1, 1994
Adhesions after extensive gynecologic surgery: clinical significance, etiology, and preventionB J Monk, M L Berman, F J Montz
American Journal of Obstetrics and Gynecology|July 1, 2008
Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive diseaseMark I Hunter, Bradley J Monk, Krishnansu S Tewari
American Journal of Obstetrics and Gynecology|November 21, 2008
Green tea catechins for treatment of external genital wartsSara M Meltzer, Bradley J Monk, Krishnansu S Tewari
Expert Review of Pharmacoeconomics & Outcomes Research|July 21, 2012
Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancerDana M Chase, Lari B Wenzel, Bradley J Monk
The Journal of Bone and Joint Surgery. British Volume|May 31, 2001
Instability due to unrecognised fracture-subluxations after apparently isolated injuries of the cervical spineP Madhavan, J Monk, J Wilson-MacDonald, et al.
Gynecologic Oncology|February 28, 2017
The development and use of vascular targeted therapy in ovarian cancerDana M Chase, David J Chaplin, Bradley J Monk
Nature Reviews. Clinical Oncology|January 3, 2025
Treatment advances across the cervical cancer spectrumAlex A Francoeur, Bradley J Monk, Krishnansu S Tewari
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directionsBradley J Monk, Krishnansu S Tewari, Wui-Jin Koh
Trends in Molecular Medicine|April 23, 2004
Selective depletion of activated T cells: the CD40L-specific antibody experienceRoseanna E G Hargreaves, Nicola J Monk, Stipo Jurcevic
Pageof 74

Showing results (51-60 of 738) with videos related to

Sort By:
Pageof 74
Current Oncology Reports|June 8, 2001
Prevention of cervical cancer with vaccinesS S Im, B J Monk, L P Villarreal
American Journal of Obstetrics and Gynecology|May 1, 1994
Adhesions after extensive gynecologic surgery: clinical significance, etiology, and preventionB J Monk, M L Berman, F J Montz
American Journal of Obstetrics and Gynecology|July 1, 2008
Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive diseaseMark I Hunter, Bradley J Monk, Krishnansu S Tewari
American Journal of Obstetrics and Gynecology|November 21, 2008
Green tea catechins for treatment of external genital wartsSara M Meltzer, Bradley J Monk, Krishnansu S Tewari
Expert Review of Pharmacoeconomics & Outcomes Research|July 21, 2012
Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancerDana M Chase, Lari B Wenzel, Bradley J Monk
The Journal of Bone and Joint Surgery. British Volume|May 31, 2001
Instability due to unrecognised fracture-subluxations after apparently isolated injuries of the cervical spineP Madhavan, J Monk, J Wilson-MacDonald, et al.
Gynecologic Oncology|February 28, 2017
The development and use of vascular targeted therapy in ovarian cancerDana M Chase, David J Chaplin, Bradley J Monk
Nature Reviews. Clinical Oncology|January 3, 2025
Treatment advances across the cervical cancer spectrumAlex A Francoeur, Bradley J Monk, Krishnansu S Tewari
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directionsBradley J Monk, Krishnansu S Tewari, Wui-Jin Koh
Trends in Molecular Medicine|April 23, 2004
Selective depletion of activated T cells: the CD40L-specific antibody experienceRoseanna E G Hargreaves, Nicola J Monk, Stipo Jurcevic
Pageof 74